Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

TCRX

TScan Therapeutics (TCRX)

TScan Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:TCRX
DatumZeitQuelleÜberschriftSymbolFirma
14/06/202422h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TCRXTScan Therapeutics Inc
14/06/202422h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TCRXTScan Therapeutics Inc
14/06/202422h05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TCRXTScan Therapeutics Inc
14/06/202413h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRXTScan Therapeutics Inc
14/06/202413h00GlobeNewswire Inc.TScan Therapeutics Announces Updates to its Board of DirectorsNASDAQ:TCRXTScan Therapeutics Inc
30/05/202413h00GlobeNewswire Inc.TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare ConferenceNASDAQ:TCRXTScan Therapeutics Inc
29/05/202413h00GlobeNewswire Inc.TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its Two Lead TCR-T Therapy Candidates for the Treatment of Heme MalignanciesNASDAQ:TCRXTScan Therapeutics Inc
13/05/202413h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCRXTScan Therapeutics Inc
13/05/202413h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRXTScan Therapeutics Inc
13/05/202413h00GlobeNewswire Inc.TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:TCRXTScan Therapeutics Inc
09/05/202413h00GlobeNewswire Inc.TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid TumorsNASDAQ:TCRXTScan Therapeutics Inc
24/04/202422h05GlobeNewswire Inc.TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual MeetingNASDAQ:TCRXTScan Therapeutics Inc
24/04/202417h03GlobeNewswire Inc.TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional SharesNASDAQ:TCRXTScan Therapeutics Inc
22/04/202423h01GlobeNewswire Inc.TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual MeetingNASDAQ:TCRXTScan Therapeutics Inc
19/04/202416h05GlobeNewswire Inc.TScan Therapeutics Announces Closing of Upsized Public OfferingNASDAQ:TCRXTScan Therapeutics Inc
17/04/202406h30GlobeNewswire Inc.TScan Therapeutics Announces Pricing of Upsized $150 Million Public OfferingNASDAQ:TCRXTScan Therapeutics Inc
16/04/202422h25GlobeNewswire Inc.TScan Therapeutics Announces Launch of $125 Million Proposed Public OfferingNASDAQ:TCRXTScan Therapeutics Inc
16/04/202422h01GlobeNewswire Inc.TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term PrioritiesNASDAQ:TCRXTScan Therapeutics Inc
08/04/202414h00GlobeNewswire Inc.TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical OfficerNASDAQ:TCRXTScan Therapeutics Inc
02/04/202413h00GlobeNewswire Inc.TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:TCRXTScan Therapeutics Inc
06/03/202422h11Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TCRXTScan Therapeutics Inc
06/03/202422h05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TCRXTScan Therapeutics Inc
06/03/202413h30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TCRXTScan Therapeutics Inc
06/03/202413h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRXTScan Therapeutics Inc
14/02/202422h45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TCRXTScan Therapeutics Inc
29/01/202413h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRXTScan Therapeutics Inc
11/12/202314h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRXTScan Therapeutics Inc
07/12/202313h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRXTScan Therapeutics Inc
09/11/202313h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCRXTScan Therapeutics Inc
09/11/202313h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRXTScan Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TCRX

Kürzlich von Ihnen besucht

Delayed Upgrade Clock